Stay updated on Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.

Latest updates to the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page
- Check3 days agoChange DetectedNew screenshot shows a minor UI/layout update to the Record History page without altering the listed study data or version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check24 days agoChange DetectedUpdate: Added October 2025 study status entries and date, removed April 2025 status.SummaryDifference1%

- Check32 days agoChange DetectedCore page content updated to include a funding-status notice and operating-status guidance, plus a version upgrade from v3.1.0 to v3.2.0.SummaryDifference11%

- Check39 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.SummaryDifference0.3%

- Check54 days agoChange DetectedThe page now shows revision v3.0.2, replacing v3.0.1 to indicate a new release. The 'Back to Top' link was removed, with no other significant content changes.SummaryDifference0.7%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.7%

Stay in the know with updates to Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.